Latest news
Researchers subvert plasmids to combat antibiotic resistance
Scientists have devised a way to track the evolution and spread of antibiotic resistance in individual bacteria by measuring competition among plasmids. Plasmids evolve independently but also help drive bacterial evolution, including the development of resistance to antimicrobial compounds. They are the primary way that resistance can jump from one type of bacteria to another.
Toxic gut bacteria may drive ulcerative colitis by killing protective immune cells
A toxin-secreting gut bacterium may fuel ulcerative colitis by killing protective immune cells that maintain intestinal homeostasis, according to a new study. The findings suggest potential for new treatment strategies.
Rebalancing lung repair with immune damage is key to surviving severe influenza
Recovery from deadly influenza infection may hinge on helping the lungs heal in addition to stopping the virus, according to a new study in mice, which shows that pairing modest antiviral therapies with immune modulation can restore damaged tissues and lung function, even after severe infection has taken hold.
Hear us out: scientists say garlic shows promise as a mouthwash alternative
Garlic extract demonstrates antimicrobial efficacy comparable to other widely used antiseptics and disinfectants, such as chlorhexidine, according to scientists. While garlic-based mouthwash may cause more discomfort than chlorhexidine, it offers longer-lasting residual effects.
Microbial nano-selenium breakthrough boosts tea quality and safety
Scientists developing selenium-enriched tea have identified a powerful selenium-reducing bacterium, Raoultella ornithinolytica S-1, capable of converting inorganic selenium into selenium nanoparticles (SeNPs) while simultaneously promoting plant growth.
Scientists reveal molecular cause behind “stuck” beer fermentation
Premature yeast flocculation (PYF) is a persistent issue in beer brewing, where yeast settles too early during fermentation. New research identifies multiple differential metabolites and confirmed galangin as a key factor that promotes early yeast aggregation.
Toxic gut bacteria may drive ulcerative colitis by killing protective immune cells
A toxin-secreting gut bacterium may fuel ulcerative colitis by killing protective immune cells that maintain intestinal homeostasis, according to a new study. The findings suggest potential for new treatment strategies.
Rebalancing lung repair with immune damage is key to surviving severe influenza
Recovery from deadly influenza infection may hinge on helping the lungs heal in addition to stopping the virus, according to a new study in mice, which shows that pairing modest antiviral therapies with immune modulation can restore damaged tissues and lung function, even after severe infection has taken hold.
Hear us out: scientists say garlic shows promise as a mouthwash alternative
Garlic extract demonstrates antimicrobial efficacy comparable to other widely used antiseptics and disinfectants, such as chlorhexidine, according to scientists. While garlic-based mouthwash may cause more discomfort than chlorhexidine, it offers longer-lasting residual effects.
Apriori Bio and A*STAR Infectious Diseases Labs Announce strategic partnership to advance next generation influenza vaccines
Apriori Bio and the Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) announced a strategic research partnership to co-develop and evaluate next generation self-amplifying RNA (saRNA) vaccines targeting seasonal and pandemic influenza.
Typhoid conjugate vaccine demonstrates strong safety and immunogenicity: Results from Phase 3 study
PATH and EuBiologics Co., LTD have announced Phase 3 results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj.® Multi-dose. EuTYPH-C Inj.®
CARBIOS and Wankai New Materials to build PET biorecycling plant in China
CARBIOS and Wankai New Materials, a subsidiary of Zhink Group, are committed to the large-scale deployment of CARBIOS’ PET biorecycling technology in Asia, with the first step being the construction of a PET biorecycling plant in China.
Researchers subvert plasmids to combat antibiotic resistance
Scientists have devised a way to track the evolution and spread of antibiotic resistance in individual bacteria by measuring competition among plasmids. Plasmids evolve independently but also help drive bacterial evolution, including the development of resistance to antimicrobial compounds. They are the primary way that resistance can jump from one type of bacteria to another.
Diphtheria toxin fragment harnessed to fuse lipid vesicles at neutral pH
Researchers have discovered a novel way to fuse lipid vesicles at neutral pH. By harnessing a fragment of the diphtheria toxin, the team achieved vesicle membrane fusion without the need for pre-treatment or harsh conditions, opening the door to new applications.
Scientists develop world’s first modular co-culture platform for the one-pot production of rainbow-colored bacterial cellulose
The team engineered Komagataeibacter xylinus for bacterial cellulose synthesis and Escherichia coli for natural colorant overproduction. A co-culture of these engineered strains enabled the in situ coloration of bacterial cellulose.
The road ahead: why conserving the invisible 99% of life is fundamental to planetary health
A new paper outlines how scientists came together to put together the first microbial conservation roadmap under the leadership of Applied Microbiology International President, Professor Jack Gilbert.
GSK and Fleming Initiative scientists unite to target AMR with advanced AI
GSK and the Fleming Initiative have announced six major new research programmes, called ‘Grand Challenges’ which harness some of the best scientific expertise and the latest technologies, including advanced AI, to find new ways to slow the progress of antimicrobial resistance (AMR).
Scripps Research scientists receive $1.1 million to advance AI modeling for HIV vaccine development
Scripps Research scientists will purchase high-performance computing equipment to accelerate the identification of more effective HIV vaccine candidates through enhanced computational infrastructure, reduced data-processing bottlenecks, and state-of-the-art artificial intelligence (AI) technology.